The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function
NCT07369830 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156
Last updated 2026-01-27
Summary
This study aims to propose a novel, easy-to-operate intervention strategy that effectively improves defecation function after stoma reversal and to assess its impact on the gut microbiota.The efficacy and safety of antegrade placement of probiotics into the distal deserted intestine during prophylactic stoma to improve bowel function after stoma reversal were evaluated through randomized controlled clinical trials.Observing the changes in gut microbiota during the prophylactic stoma period, the impact of probiotics on the structure of gut microbiota, and exploring the correlation between gut genera and bowel function after stoma reversal.
Conditions
Interventions
- BIOLOGICAL
-
Clostridium butyricum (live) Tablets(Meiya)
Clostridium butyricum (live) Tablet administered into the dysfunctional intestine for low dose and high dose group, while control group has no intervention
Sponsors & Collaborators
-
Characteristic Medical Center of Rocket Army
collaborator UNKNOWN -
Zhongnan Hospital
collaborator OTHER -
The First Affiliated Hospital of Nankai University
collaborator UNKNOWN -
First Affiliated Hospital of Fujian Medical University
collaborator OTHER -
Ruijin Hospital
collaborator OTHER -
Nanfang Hospital, Southern Medical Universit
collaborator UNKNOWN -
Huashan Hospital
lead OTHER
Principal Investigators
-
Xiang Jianbin, Doctor · Huashan Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-15
- Primary Completion
- 2029-03-30
- Completion
- 2029-06-30
Countries
- China
Study Locations
More Related Trials
-
Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer
NCT06898359 ·Status: COMPLETED
-
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
NCT06346093 ·Status: RECRUITING ·Phase: NA
-
Action of Synbiotics on Irradiated GI Mucosa in Rectal Cancer Treatment
NCT03420443 ·Status: COMPLETED ·Phase: NA
-
Dietary Fiber and Probiotics in Advanced Colorectal Cancer
NCT07194954 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial Comparing Staged Turnbull-Cutait Pull-through Anastomosis With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection
NCT06662643 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Safety and Efficiency of Stent-based Diverting Technique Versus Ileostomy in Rectal Cancer Patients
NCT06204497 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer
NCT05079503 ·Status: UNKNOWN ·Phase: NA
-
Gut Microbiota Reconstruction for NSCLC Immunotherapy
NCT05008861 ·Status: UNKNOWN ·Phase: PHASE1
-
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
NCT07319364 ·Status: RECRUITING ·Phase: PHASE1
-
The Gut Microbiome and Immunotherapy Response in Solid Cancers
NCT06050733 ·Status: RECRUITING
-
Study of Intraoperative Radiotherapy for Middle and Low Rectal Cancer
NCT03209336 ·Status: UNKNOWN ·Phase: NA
-
Fecal Microbiota Transplantation for Radiation-Induced Proctopathy
NCT06776029 ·Status: RECRUITING ·Phase: PHASE2
-
Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer
NCT06865521 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin
NCT06837831 ·Status: RECRUITING ·Phase: NA
-
Exploring the Predictive Effect of Intestinal and Oral Microbiota on the Efficacy of Neoadjuvant Radiotherapy and Chemotherapy for Locally Advanced Rectal Cancer Based on Machine Learning
NCT07346729 ·Status: COMPLETED
-
Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
NCT06793137 ·Status: RECRUITING ·Phase: PHASE2
-
Mesorectal Microbiome as a Prognostic Factor in Patients With Rectal Cancer
NCT04804956 ·Status: RECRUITING
-
Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma
NCT05563922 ·Status: RECRUITING ·Phase: PHASE2
-
The Study on the Efficacy and Safety of Lactobacillus Johnsonii in Combination with CapeOX and Pembrolizumab for the Treatment of MSS/pMMR Metastatic Colorectal Cancer.
NCT06823323 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Investigation of the Gut Microbiota in Acute Myeloid Leukemia Receiving Two Different Induction Therapies
NCT05123352 ·Status: UNKNOWN
-
Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy.
NCT01549782 ·Status: COMPLETED ·Phase: NA
-
Intersphincteric Resection With or Without Intraoperative Radiation in Rectal Cancer
NCT03393234 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy
NCT04333004 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Laparoscopic Assisted Transanal Total Mesorectal Excision for Rectal Cancer in Low Site
NCT03253302 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation for Preventing Gastrointestinal Symptoms in Extrapulmonary Neuroendocrine Neoplasms: A Real-World Study
NCT06924645 ·Status: NOT_YET_RECRUITING ·Phase: NA